FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new compounds of the formula (I):
wherein Ar1 means pyrazole that can be substituted with one or some groups R1, R2 or R3; Ar2 means naphthyl, tetrahydronaphthyl each of that is substituted optionally 0-1 with groups R2; X means (C5-C8)-cycloalkenyl, phenyl optionally substituted with hydroxy-group or (C1-C4)-alkoxy-group, furan, pyridinonyl, pyrazolyl, pyridinyl optionally substituted with hydroxy-group or (C1-C4)-alkoxy-group, piperidinyl; Y means a bond or saturated branched or unbranched (C1-C4)-carbon chain wherein one methylene group is optionally substituted for NH; or Y is substituted optionally and independently with oxo-group; Z means morpholine, o-group, pyridinyl, furanyl, tetrahydrofuranyl, thiomorpholinyl, pentamethylene sulfide, pentamethylene sulfone, secondary or tertiary amine wherein nitrogen atom of amino-group is bond covalently with the following groups taken among (C1-C3)-alkyl and (C1-C5)-alkoxyalkyl; R1 means (C3-C10)-alkyl that is halogenated optionally, partially or completely; R2 means branched or unbranched (C1-C6)-alkyl that is halogenated partially or completely, halogen atom; R3 means phenyl, pyrimidinyl, pyrazolyl that are substituted with a single branched or unbranched (C1-C6)-alkyl, and pyridinyl optionally substituted with (C1-C3)-alkoxy-group or amino-group; W means oxygen atom (O), and its pharmaceutically acceptable salts. Compounds of the formula (I) inhibit producing cytokines that allows their applying in pharmaceutical composition for treatment of cytokine-mediated disease.
EFFECT: valuable medicinal properties of compounds and composition.
13 cl, 1 tbl, 17 sch, 38 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND METHOD FOR TREATMENT OF CYTOKINE-MEDIATED DISEASE | 2000 |
|
RU2298008C2 |
AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | 1999 |
|
RU2220142C2 |
PYRAZOLE DERIVATIVES FOR TREATMENT OF VIRAL DISEASES | 2001 |
|
RU2270832C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
1,3-DIARYL-SUBSTITUTED UREAS AS KINASE ACTIVITY MODULATORS | 2006 |
|
RU2402544C2 |
IMMUNOMODULATORY AZALIDES BASED ON UREA | 2021 |
|
RU2811591C1 |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2401265C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
METHOD FOR INHIBITION OF RAF KINASE-MEDIATED GROWTH OF TUMOR CELLS, HETEROCYCLIC UREA DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) | 1998 |
|
RU2232015C2 |
Authors
Dates
2004-12-20—Published
2000-02-16—Filed